Applied BioCode Balance Sheet Health
Financial Health criteria checks 6/6
Applied BioCode has a total shareholder equity of NT$661.0M and total debt of NT$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NT$993.2M and NT$332.2M respectively.
Key information
0%
Debt to equity ratio
NT$0
Debt
| Interest coverage ratio | n/a |
| Cash | NT$604.82m |
| Equity | NT$660.99m |
| Total liabilities | NT$332.22m |
| Total assets | NT$993.21m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: 6598's short term assets (NT$837.4M) exceed its short term liabilities (NT$101.6M).
Long Term Liabilities: 6598's short term assets (NT$837.4M) exceed its long term liabilities (NT$230.7M).
Debt to Equity History and Analysis
Debt Level: 6598 is debt free.
Reducing Debt: 6598 had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 6598 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 6598 has sufficient cash runway for more than 3 years if free cash flow continues to grow at historical rates of 24.1% each year